Advertisement News Archives - Page 2262 of 5230 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 30, 2026

Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use

Amgen has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for Repatha (evolocumab) supporting its broader use prior to a first heart attack or stroke.

Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use